Owlet launches Owlet360 subscription service for infant health insights

Owlet360 will provide caregivers personalized insights into their infant's health, sleep patterns and development using the company's pediatric health data.
By Jessica Hagen
04:46 pm
Share

Photo: Insung Jeon/Getty Images

Baby tech company Owlet has announced the launch of Owlet360, a subscription service where caregivers can access their infant's health and sleep data on the baby's development and health.

Owlet360 will provide analysis of a baby's health and sleep data as compared to other infants in the company's dataset, sleep patterns, the ability to watch and share video clips of a baby, temperature and humidity trends in a baby's room, and health metrics such as daily and weekly trends for oxygen level, movement, comfort temperature and pulse rate. 

Live vital monitoring, including oxygen-level tracking and pulse rate, as well as real-time alerts, will remain free of charge for all Owlet users.

The subscription will be available with a seven-day free trial for new and existing Owlet Dream App users in the U.S. at an introductory price of $5.99 monthly. The company says it plans to expand the service internationally later this year. 

"We believe the launch of Owlet360 marks a transformative moment not just for Owlet, but for the entire industry," Kurt Workman, Owlet cofounder and CEO, said in a statement. 

"Owlet360 is the next evolution of our connected ecosystem, leveraging our large pediatric health dataset to deliver personalized, proactive care. This is more than a subscription; it's a new standard in parenting support."

THE LARGER TREND

Owlet's offerings include its Dream Sock, which received FDA clearance in 2023 and CE Mark certification last year. The sock wraps around a baby's foot and gathers live health readings of infants 0-18 months who weigh 6-30 pounds.

The device monitors the infant's heart rate, oxygen saturation and sleep state. It also gathers waking data.

The company also offers its FDA-cleared product, BabySat, which uses pulse-oximetry technology to monitor a baby's heart rate and oxygen-saturation level, and then alerts caregivers when a reading is outside of prescribed ranges. 

Owlet became a publicly traded company through a special purpose acquisition company (SPAC) in 2021. Currently, its stock is trading at around $4.50 per share on the NYSE, down from a high of $150.78 in 2021. 

In October, the New York Stock Exchange informed the infant monitoring specialist that it regained compliance with the NYSE's continued listing standards.

In 2023, Owlet was notified by the NYSE that it was not in compliance with Section 802.01B of the NYSE-listed company manual, because its average global market capitalization over a consecutive 30-day trading day period was below $50 million, and its last reported stockholders' equity was less than $50 million.

The company raised $30 million in private placement financing in 2023 and another $9 million last year.

Share